These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2305025)

  • 1. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study.
    Walker A; Bancroft J
    Psychosom Med; 1990; 52(1):86-96. PubMed ID: 2305025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.
    Bancroft J; Rennie D
    J Psychosom Res; 1993; 37(2):195-202. PubMed ID: 8463994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between retrospective premenstrual symptom reporting and present oral contraceptive use.
    Graham CA; Sherwin BB
    J Psychosom Res; 1987; 31(1):45-53. PubMed ID: 3820145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations.
    Bäckström T; Hansson-Malmström Y; Lindhe BA; Cavalli-Björkman B; Nordenström S
    Contraception; 1992 Sep; 46(3):253-68. PubMed ID: 1451521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to self-reporting of the pre-menstrual syndrome.
    Warner P; Bancroft J
    Br J Psychiatry; 1990 Aug; 157():249-60. PubMed ID: 2224376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood, sexuality, oral contraceptives and the menstrual cycle.
    Warner P; Bancroft J
    J Psychosom Res; 1988; 32(4-5):417-27. PubMed ID: 3236269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
    Kuhl H; Gahn G; Romberg G; März W; Taubert HD
    Contraception; 1985 Jun; 31(6):583-93. PubMed ID: 2931247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
    van der Does J; Exalto N; Dieben T; Bennink HC
    Contraception; 1995 Dec; 52(6):357-61. PubMed ID: 8749599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal GABA concentration changes in women-Influence of menstrual cycle phase, hormonal contraceptive use, and correlation with premenstrual symptoms.
    De Bondt T; De Belder F; Vanhevel F; Jacquemyn Y; Parizel PM
    Brain Res; 2015 Feb; 1597():129-38. PubMed ID: 25481417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive.
    Landgren BM; Csemiczky G
    Contraception; 1991 Feb; 43(2):149-59. PubMed ID: 1828225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.
    Mansour D
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():35-41; discussion 42-3. PubMed ID: 12659405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors.
    Fraser IS; Jansen RP
    Contraception; 1983 Jun; 27(6):531-51. PubMed ID: 6413129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
    Brown C; Ling F; Wan J
    J Reprod Med; 2002 Jan; 47(1):14-22. PubMed ID: 11838304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new triphasic oral contraceptive in private practice.
    Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK
    Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.